VEGFA and endophthalmitis: We identified significant disproportionality of endophthalmitis and its related signs, such as vitritis, anterior chamber empyema, corneal edema, congestion and floaters in three anti-VEGF drugs, which is consistent with literature reports (Haddock et al., 2014).